The Triumph of Treat All

Antiretroviral therapy is a major asset in lessening HIV-related morbidity if initiated shortly after diagnosis. Most countries in sub-Saharan Africa are implementing Treat All policies providing timely ART.
While initial controlled studies showed high rates of ART initiation and retention, the impact of smaller, routine Treat All programs had not been well studied.
Researchers focused on Rwanda which implemented Treat All in July 2016. Looking at data from 2014-2017, they found a substantial increase in ART initiation within 30 days of diagnosis with strong retention 6 months later. The findings support Treat All as a workable, scalable strategy in the HIV/AIDS epidemic.
Journal of the International AIDS Society

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top